This bill modifies existing provisions regarding the sale of hemp-derived cannabinoids in Minnesota, specifically focusing on edible and topical products. It allows individuals selling edible cannabinoids to convert their registration to a comparable hemp license and introduces new regulations for the sale of these products. Key amendments include stipulations that edible cannabinoid products must not exceed 0.3 percent tetrahydrocannabinol and cannot be sold to individuals under 21 years of age. Additionally, it specifies that products intended for external use must not be consumed through combustion, vaporization, or injection, with exceptions for sublingual applications.

The bill also introduces new requirements for lower-potency hemp edible manufacturers, mandating compliance with state and local building, fire, and zoning codes, as well as maintaining sanitary conditions in licensed premises. Furthermore, it amends labeling requirements for hemp-derived topical products, removing the option to provide certain information via scannable barcodes. The bill emphasizes that products must not be marketed for the diagnosis or treatment of diseases and must not contain any unsafe additives or contaminants. Overall, these changes aim to enhance consumer safety and regulatory oversight in the sale of hemp-derived products.

Statutes affected:
Introduction: 151.72, 342.45, 342.63, 342.66